Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ADH1B | P00325 | 1/20 | 0.48 |
| ▸ | ADH1C | P00326 | 1/20 | 0.48 |
| ▸ | ADH1A | P07327 | 1/20 | 0.48 |
| ▸ | ADH4 | P08319 | 1/20 | 0.48 |
| ▸ | ADH7 | P40394 | 1/20 | 0.48 |
| ▸ | GBA1 | P04062 | 3/20 | 0.46 |
| ▸ | CASP2 | P42575 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1245747 | 1.00 | EPHX1 (0.55) | EPHX1TSHRALDH1A1CA1CA2 | |
| SCHEMBL1442886 | 1.00 | EPHX1 (0.55) | EPHX1TSHRALDH1A1CA1CA2 | |
| SCHEMBL1679325 | 1.00 | — | — | |
| SCHEMBL7526820 | 1.00 | EPHX1 (0.55) | EPHX1TSHRALDH1A1CA1CA2 | |
| SCHEMBL11676721 | 1.00 | EPHX1 (0.55) | EPHX1TSHRALDH1A1CA1CA2 | |
| SCHEMBL1065041 | 1.00 | — | — | |
| SCHEMBL39683 | 1.00 | EPHX1 (0.55) | EPHX1TSHRALDH1A1CA1CA2 | |
| SCHEMBL7031847 | 1.00 | EPHX1 (0.55) | EPHX1TSHRALDH1A1CA1CA2 | |
| SCHEMBL19812450 | 1.00 | EPHX1 (0.55) | EPHX1TSHRALDH1A1CA1CA2 | |
| SCHEMBL45417 | 1.00 | EPHX1 (0.55) | EPHX1TSHRALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2584896-A2 | HERBICIDAL COMPOSITIONS | BASF SE (DE) | 2013-05-01 | — | — | EP | disclosed |
| US-20130102463-A1 | Herbicidal Compositions | BASF SE (DE) | 2013-04-25 | — | — | US | disclosed |
| WO-2011161105-A2 | HERBICIDAL COMPOSITIONS | BASF SE (DE) | 2011-12-29 | — | — | WO | disclosed |
| CN-1681864-A | Thermoplastic polymer compound, thermoplastic polymer composition, antistat and resin composition | MITSUI TAKEDA CHEMICALS INC (JP) | 2005-10-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102463-A1 | Herbicidal Compositions | PPOX, PAOX, DDT | EPHX1 74/4885TSHR 2587/4885ALDH1A1 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.